Published in Lancet on April 08, 1967
Burn wound infections. Clin Microbiol Rev (2006) 4.81
Immunological studies in children undergoing tonsillectomy. Clin Exp Immunol (1973) 2.83
The human primary immune response to keyhole limpet haemocyanin: interrelationships of delayed hypersensitivity, antibody response and in vitro blast transformation. Clin Exp Immunol (1970) 2.40
Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease. Br Med J (1972) 1.84
Abnormalities of in vitro lymphocyte responses during rubella virus infections. J Exp Med (1968) 1.82
Clinical review: immunodepression in the surgical patient and increased susceptibility to infection. Crit Care (2002) 1.54
Inhalational anesthetics induce cell damage by disruption of intracellular calcium homeostasis with different potencies. Anesthesiology (2008) 1.52
The effect of anaesthesia on the lymphocyte response to phytohaemagglutinin. Clin Exp Immunol (1974) 1.37
Depression of lymphocyte responses after surgical trauma. Br J Exp Pathol (1973) 1.29
Association of a circulating immunosuppressive polypeptide with operative and accidental trauma. Ann Surg (1977) 1.26
Immune and metabolic effects of arginine in the surgical patient. Ann Surg (1988) 1.16
Association of sepsis with an immunosuppressive polypeptide in the serum of burn patients. Ann Surg (1978) 1.15
Synergistic effect of cortisol and prostaglandin E2 on the PHA response. Relation to immunosuppression induced by trauma. Clin Exp Immunol (1976) 1.11
Depression of immunological responses due to surgery. A model in the guinea-pig. Immunology (1974) 1.10
The in vitro transformation of thymocytes and lymphocytes from humans, rabbits and guinea-pigs and from thymomas. Clin Exp Immunol (1968) 1.01
Effect of surgery on tumour-directed leucocyte responses. Br Med J (1975) 0.99
Host immune status in uraemia. I. Cell-mediated immune mechanisms. Clin Exp Immunol (1980) 0.98
Induction of Fas-mediated apoptosis on circulating lymphocytes by surgical stress. Ann Surg (1996) 0.96
Post-operative depression of antibody-dependent lymphocyte cytotoxicity following minor surgery and anaesthesia. Immunology (1976) 0.90
Intermittent corticotrophin therapy. Study of lymphocyte transformation in vitro in rheumatoid arthritis. Ann Rheum Dis (1969) 0.86
Response of agammaglobulinaemic lymphocytes in mixed lymphocyte culture. Clin Exp Immunol (1969) 0.85
Lymphocyte transformation in large bowel cancer. Br J Cancer (1973) 0.84
Tumour immunology and the gut. Gut (1975) 0.84
Impaired production of interleukin-2 after surgery. Clin Exp Immunol (1985) 0.83
[Investigations of unspecific immune reactivity in patients with head and neck carcinoma (author's transl)]. Arch Otorhinolaryngol (1981) 0.81
Tumor-directed cellular immunity in malignant melanoma and its modification by surgical treatment. Yale J Biol Med (1973) 0.80
Prospective randomized comparison of cefodizime versus cefuroxime for perioperative prophylaxis in patients undergoing coronary artery bypass grafting. Antimicrob Agents Chemother (1997) 0.79
Immunological responsiveness after transurethral resection of the prostate: general versus spinal anaesthetic. Clin Exp Immunol (1982) 0.79
Clinical significance of immunopathological findings in patients with post-pericardiotomy syndrome. II. The significance of serum inhibition and rosette inhibitory factors. Clin Exp Immunol (1979) 0.78
TEEM-test studies on effect of aprotinin on in vitro response of cancer patients' lymphocytes to PPD. Br J Cancer (1978) 0.78
Depression of the generation of cell-mediated cytotoxicity by suppressor cells after surgery. Clin Exp Immunol (1983) 0.78
The "in vitro skin test": a reliable and repeatable assay of immune competence in the surgical patient. Ann Surg (1981) 0.77
Pulmonary alveolar proteinosis in an infant. Arch Dis Child (1969) 0.75
The effects of halothane anaesthesia on antibody-dependent cellular cytotoxicity in rats. Immunology (1977) 0.75
Lymphocyte stimulation by autochthonous human solid tumours. Br J Cancer Suppl (1973) 0.75
British Association of Clinical Anatomists. Abstracts. Spring meeting. 13 September 1985, Newcastle-upon-Tyne. Ann R Coll Surg Engl (1986) 0.75
Immunosuppression following excision of burn eschar and syngeneic grafting in major thermal trauma. Yale J Biol Med (1985) 0.75
The control of cancer spread by the reticuloendothelial system. Ann R Coll Surg Engl (1972) 0.75
A method for testing for synergy with any number of agents. J Infect Dis (1978) 9.52
Is azathioprine a better immunosuppressive than 6-mercaptopurine? Clin Exp Immunol (1971) 3.47
Synergy, additivism and antagonism in immunosuppression. A critical review. Clin Exp Immunol (1977) 2.89
Criteria for analyzing interactions between biologically active agents. Adv Cancer Res (1981) 2.49
The expected effect of a combination of agents: the general solution. J Theor Biol (1985) 2.06
Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial cell lines. Cancer Res (1986) 1.94
In vivo biological activity of the components of haematoporphyrin derivative. Br J Cancer (1982) 1.82
Photodynamic destruction of human bladder carcinoma. Br J Cancer (1975) 1.55
Cerebral photosensitisation by haematoporphyrin derivative. Evidence for an endothelial site of action. Br J Cancer (1986) 1.53
Time-dependent immunosuppressive effects of anti-thymocyte serum. Nature (1967) 1.48
meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity. Br J Cancer (1986) 1.47
Dose-response curves for agents that impair cell reproductive integrity. A fundamental difference between dose-response curves of antimetabolites and those for radiation and alkylating agents. Br J Cancer (1969) 1.44
Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results. Br J Cancer (1991) 1.42
Cardiac and pulmonary effects of high doses of cyclophosphamide and isophosphamide. Cancer Res (1974) 1.36
Depression of lymphocyte responses after surgical trauma. Br J Exp Pathol (1973) 1.29
Correlations between methods for measurement of synergy. J Infect Dis (1980) 1.29
The growth of human tumours in immunosuppressed mice and their response to chemotherapy. Br J Cancer (1974) 1.27
In vivo determination of the fractional kill of human tumor cells by chemotherapeutic agents. Cancer Chemother Rep (1972) 1.26
Cell respiration as a requirement for antibody release in vitro. Nature (1968) 1.21
Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers. Biochem J (1989) 1.19
Intracavitary chemotherapy for multiple non-invasive bladder tumours. Br J Urol (1971) 1.14
Synergistic effect of cortisol and prostaglandin E2 on the PHA response. Relation to immunosuppression induced by trauma. Clin Exp Immunol (1976) 1.11
Disturbed immune reactions following surgery. Br J Surg (1967) 1.06
Electronic techniques for the control of adult urinary incontinence. Br J Urol (1969) 1.06
The therapeutic significance of the dose response curve for antilymphocytic serum. Transplantation (1971) 1.02
The effect of microsomal enzyme inhibition on the immunosuppressive and toxic effects of cyclophosphamide. Clin Exp Immunol (1973) 1.01
The accuracy of ultrasound in the measurement of changes in bladder volume. Br J Urol (1983) 1.00
Immunosuppression by L-asparaginase. Nature (1970) 0.99
The use of transabdominal ultrasound in the detection of early bladder tumours. Br J Urol (1986) 0.99
The relation between the physico-chemical properties and immunosuppressive effects of an homologous series of sulphonic acid esters. Immunology (1967) 0.97
Urological complications of traumatic diastasis of the symphysis pubis in the female. Br J Urol (1981) 0.95
Effects of L-asparaginase on lymphocyte-target cell reactions in vitro. Nature (1970) 0.95
The sensitivity to chemotherapeutic agents of a rat tumour grown in immunosuppressed mice. Br J Cancer (1971) 0.95
Is delayed treatment justified in carcinoma of the prostate? Br J Urol (1985) 0.95
Synergy with double and triple antibiotic combinations compared. J Antimicrob Chemother (1983) 0.95
Wavelength and light-dose dependence in tumour phototherapy with haematoporphyrin derivative. Br J Cancer (1985) 0.94
Immunosuppressive agents: the design of selective therapeutic schedules. Antibiot Chemother (1969) 0.93
The rabbit VX2 tumour as a model for carcinomas of the tongue and larynx. Acta Otolaryngol (1989) 0.91
Synergy assessment with growth curves. J Infect Dis (1984) 0.90
The role of preoperative embolization in renal cell carcinoma. J Urol (1984) 0.90
Radiosensitivity of immunologically activated cells. Nature (1966) 0.89
Minor synergy and antagonism may be clinically important. J Antimicrob Chemother (1987) 0.88
HPD - a study of its components and their properties. Adv Exp Med Biol (1983) 0.87
The use of ultrasound in the investigation of prostatism. Br J Urol (1982) 0.87
Selective suppression of murine antibody-dependent cell-mediated cytotoxicity by azathioprine. Transplantation (1975) 0.87
The localization of haemolytic antibody in sections of lymphoid organs: an improved method. Immunology (1970) 0.84
Synergy and antagonism are not synonymous with therapeutic advantage and disadvantage. J Antimicrob Chemother (1988) 0.84
Role of mitosis and mitotic inhibition in the immunosuppressive action of thioguanine. Nature (1966) 0.83
Diagnosis of clinically occult bladder cancer by in vivo staining with methylene blue. Br J Urol (1990) 0.83
Consequences of synergy between environmental carcinogens. Environ Res (1985) 0.82
Time-dependence and selectivity of immunosuppressive agents. Immunology (1979) 0.82
Protective effects of a novel perfluorochemical emulsion in photodynamic therapy. Biomater Artif Cells Immobilization Biotechnol (1992) 0.82
The effect of cysteine on the immunosuppressive activity of busulphan, cyclophosphamide and nitrogen mustard. Br J Cancer (1971) 0.82
Transplantation and immunosuppression. Mod Trends Immunol (1967) 0.81
Effect of cyclophosphamide on the homograft response in the guinea pig. Transplantation (1965) 0.81
Hyponatraemia during transurethral resection--its practical prevention. Br J Urol (1984) 0.81
Effect of some metabolic inhibitors on plaque formation in Jerne plates. Nature (1967) 0.81
The mode of action of cytotoxic drugs. Proc R Soc Med (1970) 0.80
Differential asparaginase sensitivity of T-cell and B-cell responses. Clin Exp Immunol (1973) 0.80
The management of superficial bladder tumours with intravesical Epodyl. Br J Urol (1973) 0.80
Porphyrin sensitizers in tumour phototherapy. Novel sensitizers of the chlorin and bacteriochlorin class with amphiphilic properties. J Photochem Photobiol B (1990) 0.79
Urinary tuberculosis. Postgrad Med J (1971) 0.79
Morbidity and mortality in 100 consecutive radical cystectomies. Br J Urol (1982) 0.78
Immunosuppressive agents: generation and consequences of differing dose-response curves. Proc R Soc Med (1972) 0.78
Letter: Predicting response of human cancer to chemotherapy. Lancet (1974) 0.78
Research ethics and deception. Lancet (1980) 0.78
Flat carcinoma in Situ of bladder. Br J Urol (1975) 0.78
Pituitary ablation in the relief of pain in advanced prostatic carcinoma. Br J Urol (1980) 0.78
Intercellular immunological controls and modulation of cyclic AMP levels. Some doubts. Immunology (1976) 0.77
Photodynamic therapy of a mouse glioma: intracranial tumours are resistant while subcutaneous tumours are sensitive. Br J Cancer (1991) 0.77
Immunosuppression by platinum diamines. Br J Cancer (1971) 0.77
Neutrophil function during chemotherapy for Hodgkin's disease. Br J Cancer (1981) 0.77
Urinary diversion for incontinence--a beneficial procedure? Ann R Coll Surg Engl (1985) 0.77
Outcome in carcinoma in situ of bladder treated with intravesical bacille Calmette-Guérin. Br J Urol (1992) 0.77
Procidentia and ureteric obstruction. Br J Urol (1975) 0.75
Concepts for describing the interaction of two agents. Radiat Res (1991) 0.75
Increased therapeutic efficiency of a lipid-soluble alkylating agent incorporated in liposomes. Br J Cancer (1982) 0.75
Modes of action of immunosuppressive agents. Proc R Soc Med (1967) 0.75
Autoimmunity and immunosuppression. Proc R Soc Med (1967) 0.75
Dose-response curves for agents that impair cell reproductive integrity. The relation between dose-response curves and the design of selective regimens in cancer chemotherapy. Br J Cancer (1969) 0.75
Dermatitis due to mitomycin bladder instillations. J R Soc Med (1984) 0.75
Antagonism between radiosensitizing agents. Br J Radiol (1988) 0.75
Nephroureterectomy after radical cystectomy. J Urol (1988) 0.75
Muscle damage and recovery in the rabbit tongue following photodynamic therapy with haematoporphyrin derivative. Acta Otolaryngol (1991) 0.75
Bilateral total ureteric bypass in the management of renal tubular acidosis. Eur Urol (1979) 0.75
Long-term follow-up in patients with superficial bladder tumours treated with intravesical Epodyl. Br J Urol (1979) 0.75
Intrathecal interferon, indomethacin, and multiple sclerosis. Lancet (1987) 0.75
Rupture of the small intestine as a complication of procidentia. J Obstet Gynaecol Br Commonw (1966) 0.75
Anti-HIV synergy between dextran sulphate and zidovudine. Lancet (1987) 0.75
Prognostic factors influencing survival of patients receiving intravesical epodyl. J Urol (1982) 0.75
Subcutaneous Corynebacterium parvum in bladder cancer: a controlled study of its immunological effects. Br J Urol (1979) 0.75
Effect of L-asparaginase on germinal centre haemolysin. Nature (1971) 0.75
The last surviving cancer cell: the chances of killing it. Cancer Chemother Rep (1968) 0.75
Growth of human and rat tumours in immunosuppressed mice. J Pathol (1972) 0.75
Urinary tuberculosis. Nurs Times (1974) 0.75
Incontinence. Trans Med Soc Lond (1973) 0.75
Metastatic deposits from a previously treated carcinoma of the lung presenting as a renal cell carcinoma. Br J Radiol (1986) 0.75
The immunosuppressive effects of 5-fluorocytosine and 5-fluorouracil. Chemotherapy (1979) 0.75